← Leaderboards
Gang Zeng
University Of California Los Angeles
$2,298,493
Attributed
$2,298,493
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $516.8K · FY2007–16$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$2,298,493 · 4
By mechanism
R01$1,413,073 · 1
R21$730,920 · 2
R03$154,500 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Lily Wu$3,586,954
- Hong Wu$8,515,329
- Christopher Seet$1,554,283
- Samuel French$1,098,049
- Brian B. Gowen$3,198,237
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstateSamplingCancer PatientLaboratoriesSerumSensitivity And SpecificityTumor AntigensBaseDiagnosisAntigensAutoantibodiesFutureSpecificityDetectionProteinsPsa ScreeningClinically RelevantCohortEpitopesPeptidesResponseTechnologyMalignant Neoplasm Of LungMalignant Neoplasms
Grant awards (13)
Autoantibodies against micro RNA for Early Cancer Detection$167,475
R21 · FY2016 · CA · contact PI
A+PSA Assay for Improved Prostate Cancer Diagnosis and Risk Assessment$319,550
R01 · FY2015 · CA · contact PI
Autoantibodies against micro RNA for Early Cancer Detection$197,212
R21 · FY2015 · CA · contact PI
A+PSA Assay for Improved Prostate Cancer Diagnosis and Risk Assessment$309,964
R01 · FY2014 · CA · contact PI
A+PSA Assay for Improved Prostate Cancer Diagnosis and Risk Assessment$36,766
R01 · FY2014 · CA · contact PI
A+PSA Assay for Improved Prostate Cancer Diagnosis and Risk Assessment$300,377
R01 · FY2013 · CA · contact PI
A+PSA Assay for Improved Prostate Cancer Diagnosis and Risk Assessment$79,724
R01 · FY2013 · CA · contact PI
A+PSA Assay for Improved Prostate Cancer Diagnosis and Risk Assessment$319,550
R01 · FY2012 · CA · contact PI
A+PSA Assay for Improved Prostate Cancer Diagnosis and Risk Assessment$47,142
R01 · FY2012 · CA · contact PI
Auto-antibody plus PSA assay for patients with prostate cancer$166,755
R21 · FY2010 · CA · contact PI
Auto-antibody plus PSA assay for patients with prostate cancer$199,478
R21 · FY2009 · CA · contact PI
Epitope Array to Complement PSA Tests for Early Detection of Prostate Cancer$77,250
R03 · FY2008 · CA · contact PI
Epitope Array to Complement PSA Tests for Early Detection of Prostate Cancer$77,250
R03 · FY2007 · CA · contact PI